Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
110
Views
8
CrossRef citations to date
0
Altmetric
Original Research

An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial

Anthony Cahn1 Discovery Medicine, GlaxoSmithKline, Stevenage, UKCorrespondence[email protected]
View further author information
,
J Nicole Hamblin2 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKView further author information
,
Jon Robertson3 Biostatistics, GlaxoSmithKline, Stevenage, UKView further author information
,
Malcolm Begg2 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKORCID Iconhttps://orcid.org/0000-0001-9508-3424View further author information
ORCID Icon,
Emily Jarvis3 Biostatistics, GlaxoSmithKline, Stevenage, UKORCID Iconhttps://orcid.org/0000-0001-7187-6382View further author information
ORCID Icon,
Robert Wilson1 Discovery Medicine, GlaxoSmithKline, Stevenage, UKView further author information
,
Gordon Dear4 Mechanistic Safety & Disposition, GlaxoSmithKline, Ware, UKView further author information
,
Claudia Leemereise5 Global Clinical Sciences & Delivery, GlaxoSmithKline, Amersfoort, the NetherlandsView further author information
,
Yi Cui6 Pharma Safety, GlaxoSmithKline, Brentford, Middlesex, UKView further author information
,
Maki Mizuma7 Data Management & Strategy, GlaxoSmithKline, Tokyo, JapanView further author information
,
Mickael Montembault8 Global Clinical Sciences & Delivery, GlaxoSmithKline, Brentford, Middlesex, UKView further author information
,
Cedric Van Holsbeke9 FLUIDDA nv, Kontich, 2550, BelgiumORCID Iconhttps://orcid.org/0000-0003-0248-841XView further author information
ORCID Icon,
Wim Vos9 FLUIDDA nv, Kontich, 2550, BelgiumView further author information
,
Wilfried De Backer10 Pulmonary Medicine & Pulmonary Rehabilitation, University of Antwerp, Antwerp, BelgiumView further author information
,
Jan De Backer9 FLUIDDA nv, Kontich, 2550, BelgiumView further author information
&
Edith M Hessel2 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKORCID Iconhttps://orcid.org/0000-0002-2339-4482View further author information
ORCID Icon show all
Pages 1607-1619 | Published online: 03 Jun 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Mario Cazzola, Nicola A Hanania, Clive P Page & Maria Gabriella Matera. (2023) Novel Anti-Inflammatory Approaches to COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1333-1352.
Read now
Peng Guo, Rui Li, Tie Hua Piao, Chun Lan Wang, Xiao Lu Wu & Hong Yan Cai. (2022) Pathological Mechanism and Targeted Drugs of COPD. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1565-1575.
Read now
Jennifer M Wang, Sundaresh Ram, Wassim W Labaki, MeiLan K Han & Craig J Galbán. (2022) CT-Based Commercial Software Applications: Improving Patient Care Through Accurate COPD Subtyping. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 919-930.
Read now

Articles from other publishers (5)

Malcolm Begg, Augustin Amour, Emily Jarvis, Teresa Tang, Sara Santos Franco, Andrew Want, Misba Beerahee, Disala Fernando, Yakshitha Karkera, Clare Sander, Thomas Southworth, Dave Singh, Jonathan Clark, Sergey Nejentsev, Klaus Okkenhaug, Alison Condliffe, Anita Chandra, Anthony Cahn & Edward Banham Hall. (2023) An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome. Pulmonary Pharmacology & Therapeutics 79, pages 102201.
Crossref
Suvadeep Mal, Udita Malik, Monalisa Mahapatra, Abhishek Mishra, Dilipkumar Pal & Sudhir K. Paidesetty. (2022) A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective. Drug Development Research 83:7, pages 1469-1504.
Crossref
Sarah Diver, Chris E. Brightling & Neil J. Greening. (2022) Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunology and Allergy Clinics of North America 42:3, pages 671-690.
Crossref
Isabel UWAGBOE, Ian M. ADCOCK, Federica LO BELLO, Gaetano CARAMORI & Sharon MUMBY. (2022) New drugs under development for COPD. Minerva Medica 113:3.
Crossref
Merete B. Long & James D. Chalmers. (2022) Treating Neutrophilic Inflammation in Airways Diseases. Archivos de Bronconeumología 58:6, pages 463-465.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.